Hippocampal volume in young patients with major depression before and after combined antidepressive therapy - a monocentric, double-blind, placebo-controlled trial

Trial Profile

Hippocampal volume in young patients with major depression before and after combined antidepressive therapy - a monocentric, double-blind, placebo-controlled trial

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Mirtazapine (Primary) ; Venlafaxine (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Acronyms COATS
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 19 Jan 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 16 Jan 2008 The expected completion date for this trial is now 1 Dec 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top